Literature DB >> 26898737

The Production of Solid Dosage Forms from Non-Degradable Polymers.

Ian Major1, Evert Fuenmayor, Christopher McConville.   

Abstract

Non-degradable polymers have an important function in medicine. Solid dosage forms for longer term implantation require to be constructed from materials that will not degrade or erode over time and also offer the utmost biocompatibility and biostability. This review details the three most important non-degradable polymers for the production of solid dosage forms - silicone elastomer, ethylene vinyl acetate and thermoplastic polyurethane. The hydrophobic, thermoset silicone elastomer is utilised in the production of a broad range of devices, from urinary catheter tubing for the prevention of biofilm to intravaginal rings used to prevent HIV transmission. Ethylene vinyl acetate, a hydrophobic thermoplastic, is the material of choice of two of the world's leading forms of contraception - Nuvaring® and Implanon®. Thermoplastic polyurethane has such a diverse range of building blocks that this one polymer can be hydrophilic or hydrophobic. Yet, in spite of this versatility, it is only now finding utility in commercialised drug delivery systems. Separately then one polymer has a unique ability that differentiates it from the others and can be applied in a specific drug delivery application; but collectively these polymers provide a rich palette of material and drug delivery options to empower formulation scientists in meeting even the most demanding of unmet clinical needs. Therefore, these polymers have had a long history in controlled release, from the very beginning even, and it is pertinent that this review examines briefly this history while also detailing the state-of-the-art academic studies and inventions exploiting these materials. The paper also outlines the different production methods required to manufacture these solid dosage forms as many of the processes are uncommon to the wider pharmaceutical industry.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26898737     DOI: 10.2174/1381612822666160217141049

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

1.  Disseminated injection of vincristine-loaded silk gel improves the suppression of neuroblastoma tumor growth.

Authors:  Jasmine Zeki; Jordan S Taylor; Burcin Yavuz; Jeannine Coburn; Naohiko Ikegaki; David L Kaplan; Bill Chiu
Journal:  Surgery       Date:  2018-07-27       Impact factor: 3.982

2.  Manipulation of variables in local controlled release vincristine treatment in neuroblastoma.

Authors:  Jeannine M Coburn; Jamie Harris; Rachel Cunningham; Jasmine Zeki; David L Kaplan; Bill Chiu
Journal:  J Pediatr Surg       Date:  2017-09-04       Impact factor: 2.545

Review 3.  Approaches in Polymeric Nanoparticles for Vaginal Drug Delivery: A Review of the State of the Art.

Authors:  Gerardo Leyva-Gómez; Elizabeth Piñón-Segundo; Néstor Mendoza-Muñoz; María L Zambrano-Zaragoza; Susana Mendoza-Elvira; David Quintanar-Guerrero
Journal:  Int J Mol Sci       Date:  2018-05-23       Impact factor: 5.923

4.  Material Considerations for Fused-Filament Fabrication of Solid Dosage Forms.

Authors:  Evert Fuenmayor; Martin Forde; Andrew V Healy; Declan M Devine; John G Lyons; Christopher McConville; Ian Major
Journal:  Pharmaceutics       Date:  2018-04-02       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.